United States Viral Clearance Market Report 2017

October 2017 | 95 pages | ID: U544886284FPEN
QYResearch

Abstracts

In this report, the United States Viral Clearance market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Viral Clearance in these regions, from 2012 to 2022 (forecast).

United States Viral Clearance market competition by top manufacturers/players, with Viral Clearance sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Clean Cells
• Charles River Laboratories International
• Lonza Group
• Merck KGaA
• BioReliance
• Texcell
• WuXi PharmaTech
• Avance Biosciences
• BSL BIOSERVICE

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Viral Detection Method
• Viral Removal Method
• Viral Inactivation Method

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Viral Clearance for each application, including

• Blood & Blood Products
• Cellular & Gene Therapy Products
• Stem Cell Products
• Tissue & Tissue Products
• Vaccines and Therapeutics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Viral Clearance Market Report 2017

1 VIRAL CLEARANCE OVERVIEW

1.1 Product Overview and Scope of Viral Clearance
1.2 Classification of Viral Clearance by Product Category
  1.2.1 United States Viral Clearance Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Viral Clearance Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Viral Detection Method
  1.2.4 Viral Removal Method
  1.2.5 Viral Inactivation Method
1.3 United States Viral Clearance Market by Application/End Users
  1.3.1 United States Viral Clearance Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Blood & Blood Products
  1.3.3 Cellular & Gene Therapy Products
  1.3.4 Stem Cell Products
  1.3.5 Tissue & Tissue Products
  1.3.6 Vaccines and Therapeutics
1.4 United States Viral Clearance Market by Region
  1.4.1 United States Viral Clearance Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Viral Clearance Status and Prospect (2012-2022)
  1.4.3 Southwest Viral Clearance Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Viral Clearance Status and Prospect (2012-2022)
  1.4.5 New England Viral Clearance Status and Prospect (2012-2022)
  1.4.6 The South Viral Clearance Status and Prospect (2012-2022)
  1.4.7 The Midwest Viral Clearance Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Viral Clearance (2012-2022)
  1.5.1 United States Viral Clearance Sales and Growth Rate (2012-2022)
  1.5.2 United States Viral Clearance Revenue and Growth Rate (2012-2022)

2 UNITED STATES VIRAL CLEARANCE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Viral Clearance Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Viral Clearance Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Viral Clearance Average Price by Players/Suppliers (2012-2017)
2.4 United States Viral Clearance Market Competitive Situation and Trends
  2.4.1 United States Viral Clearance Market Concentration Rate
  2.4.2 United States Viral Clearance Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Viral Clearance Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES VIRAL CLEARANCE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Viral Clearance Sales and Market Share by Region (2012-2017)
3.2 United States Viral Clearance Revenue and Market Share by Region (2012-2017)
3.3 United States Viral Clearance Price by Region (2012-2017)

4 UNITED STATES VIRAL CLEARANCE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Viral Clearance Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Viral Clearance Revenue and Market Share by Type (2012-2017)
4.3 United States Viral Clearance Price by Type (2012-2017)
4.4 United States Viral Clearance Sales Growth Rate by Type (2012-2017)

5 UNITED STATES VIRAL CLEARANCE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Viral Clearance Sales and Market Share by Application (2012-2017)
5.2 United States Viral Clearance Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES VIRAL CLEARANCE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Clean Cells
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Viral Clearance Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Clean Cells Viral Clearance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Charles River Laboratories International
  6.2.2 Viral Clearance Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Charles River Laboratories International Viral Clearance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Lonza Group
  6.3.2 Viral Clearance Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Lonza Group Viral Clearance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck KGaA
  6.4.2 Viral Clearance Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck KGaA Viral Clearance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 BioReliance
  6.5.2 Viral Clearance Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 BioReliance Viral Clearance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Texcell
  6.6.2 Viral Clearance Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Texcell Viral Clearance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 WuXi PharmaTech
  6.7.2 Viral Clearance Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 WuXi PharmaTech Viral Clearance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Avance Biosciences
  6.8.2 Viral Clearance Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Avance Biosciences Viral Clearance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 BSL BIOSERVICE
  6.9.2 Viral Clearance Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 BSL BIOSERVICE Viral Clearance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 VIRAL CLEARANCE MANUFACTURING COST ANALYSIS

7.1 Viral Clearance Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Viral Clearance

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Viral Clearance Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Viral Clearance Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VIRAL CLEARANCE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Viral Clearance Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Viral Clearance Sales Volume Forecast by Type (2017-2022)
11.3 United States Viral Clearance Sales Volume Forecast by Application (2017-2022)
11.4 United States Viral Clearance Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Viral Clearance
Figure United States Viral Clearance Market Size (K Units) by Type (2012-2022)
Figure United States Viral Clearance Sales Volume Market Share by Type (Product Category) in 2016
Figure Viral Detection Method Product Picture
Figure Viral Removal Method Product Picture
Figure Viral Inactivation Method Product Picture
Figure United States Viral Clearance Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Viral Clearance by Application in 2016
Figure Blood & Blood Products Examples
Table Key Downstream Customer in Blood & Blood Products
Figure Cellular & Gene Therapy Products Examples
Table Key Downstream Customer in Cellular & Gene Therapy Products
Figure Stem Cell Products Examples
Table Key Downstream Customer in Stem Cell Products
Figure Tissue & Tissue Products Examples
Table Key Downstream Customer in Tissue & Tissue Products
Figure Vaccines and Therapeutics Examples
Table Key Downstream Customer in Vaccines and Therapeutics
Figure United States Viral Clearance Market Size (Million USD) by Region (2012-2022)
Figure The West Viral Clearance Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Viral Clearance Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Viral Clearance Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Viral Clearance Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Viral Clearance Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Viral Clearance Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Viral Clearance Sales (K Units) and Growth Rate (2012-2022)
Figure United States Viral Clearance Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Viral Clearance Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Viral Clearance Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Viral Clearance Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Viral Clearance Sales Share by Players/Suppliers
Figure 2017 United States Viral Clearance Sales Share by Players/Suppliers
Figure United States Viral Clearance Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Viral Clearance Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Viral Clearance Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Viral Clearance Revenue Share by Players/Suppliers
Figure 2017 United States Viral Clearance Revenue Share by Players/Suppliers
Table United States Market Viral Clearance Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Viral Clearance Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Viral Clearance Market Share of Top 3 Players/Suppliers
Figure United States Viral Clearance Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Viral Clearance Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Viral Clearance Product Category
Table United States Viral Clearance Sales (K Units) by Region (2012-2017)
Table United States Viral Clearance Sales Share by Region (2012-2017)
Figure United States Viral Clearance Sales Share by Region (2012-2017)
Figure United States Viral Clearance Sales Market Share by Region in 2016
Table United States Viral Clearance Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Viral Clearance Revenue Share by Region (2012-2017)
Figure United States Viral Clearance Revenue Market Share by Region (2012-2017)
Figure United States Viral Clearance Revenue Market Share by Region in 2016
Table United States Viral Clearance Price (USD/Unit) by Region (2012-2017)
Table United States Viral Clearance Sales (K Units) by Type (2012-2017)
Table United States Viral Clearance Sales Share by Type (2012-2017)
Figure United States Viral Clearance Sales Share by Type (2012-2017)
Figure United States Viral Clearance Sales Market Share by Type in 2016
Table United States Viral Clearance Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Viral Clearance Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Viral Clearance by Type (2012-2017)
Figure Revenue Market Share of Viral Clearance by Type in 2016
Table United States Viral Clearance Price (USD/Unit) by Types (2012-2017)
Figure United States Viral Clearance Sales Growth Rate by Type (2012-2017)
Table United States Viral Clearance Sales (K Units) by Application (2012-2017)
Table United States Viral Clearance Sales Market Share by Application (2012-2017)
Figure United States Viral Clearance Sales Market Share by Application (2012-2017)
Figure United States Viral Clearance Sales Market Share by Application in 2016
Table United States Viral Clearance Sales Growth Rate by Application (2012-2017)
Figure United States Viral Clearance Sales Growth Rate by Application (2012-2017)
Table Clean Cells Basic Information List
Table Clean Cells Viral Clearance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Clean Cells Viral Clearance Sales Growth Rate (2012-2017)
Figure Clean Cells Viral Clearance Sales Market Share in United States (2012-2017)
Figure Clean Cells Viral Clearance Revenue Market Share in United States (2012-2017)
Table Charles River Laboratories International Basic Information List
Table Charles River Laboratories International Viral Clearance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Charles River Laboratories International Viral Clearance Sales Growth Rate (2012-2017)
Figure Charles River Laboratories International Viral Clearance Sales Market Share in United States (2012-2017)
Figure Charles River Laboratories International Viral Clearance Revenue Market Share in United States (2012-2017)
Table Lonza Group Basic Information List
Table Lonza Group Viral Clearance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lonza Group Viral Clearance Sales Growth Rate (2012-2017)
Figure Lonza Group Viral Clearance Sales Market Share in United States (2012-2017)
Figure Lonza Group Viral Clearance Revenue Market Share in United States (2012-2017)
Table Merck KGaA Basic Information List
Table Merck KGaA Viral Clearance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck KGaA Viral Clearance Sales Growth Rate (2012-2017)
Figure Merck KGaA Viral Clearance Sales Market Share in United States (2012-2017)
Figure Merck KGaA Viral Clearance Revenue Market Share in United States (2012-2017)
Table BioReliance Basic Information List
Table BioReliance Viral Clearance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioReliance Viral Clearance Sales Growth Rate (2012-2017)
Figure BioReliance Viral Clearance Sales Market Share in United States (2012-2017)
Figure BioReliance Viral Clearance Revenue Market Share in United States (2012-2017)
Table Texcell Basic Information List
Table Texcell Viral Clearance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Texcell Viral Clearance Sales Growth Rate (2012-2017)
Figure Texcell Viral Clearance Sales Market Share in United States (2012-2017)
Figure Texcell Viral Clearance Revenue Market Share in United States (2012-2017)
Table WuXi PharmaTech Basic Information List
Table WuXi PharmaTech Viral Clearance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure WuXi PharmaTech Viral Clearance Sales Growth Rate (2012-2017)
Figure WuXi PharmaTech Viral Clearance Sales Market Share in United States (2012-2017)
Figure WuXi PharmaTech Viral Clearance Revenue Market Share in United States (2012-2017)
Table Avance Biosciences Basic Information List
Table Avance Biosciences Viral Clearance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Avance Biosciences Viral Clearance Sales Growth Rate (2012-2017)
Figure Avance Biosciences Viral Clearance Sales Market Share in United States (2012-2017)
Figure Avance Biosciences Viral Clearance Revenue Market Share in United States (2012-2017)
Table BSL BIOSERVICE Basic Information List
Table BSL BIOSERVICE Viral Clearance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BSL BIOSERVICE Viral Clearance Sales Growth Rate (2012-2017)
Figure BSL BIOSERVICE Viral Clearance Sales Market Share in United States (2012-2017)
Figure BSL BIOSERVICE Viral Clearance Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral Clearance
Figure Manufacturing Process Analysis of Viral Clearance
Figure Viral Clearance Industrial Chain Analysis
Table Raw Materials Sources of Viral Clearance Major Players/Suppliers in 2016
Table Major Buyers of Viral Clearance
Table Distributors/Traders List
Figure United States Viral Clearance Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Viral Clearance Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Viral Clearance Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Viral Clearance Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Viral Clearance Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Viral Clearance Sales Volume (K Units) Forecast by Type in 2022
Table United States Viral Clearance Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Viral Clearance Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Viral Clearance Sales Volume (K Units) Forecast by Application in 2022
Table United States Viral Clearance Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Viral Clearance Sales Volume Share Forecast by Region (2017-2022)
Figure United States Viral Clearance Sales Volume Share Forecast by Region (2017-2022)
Figure United States Viral Clearance Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources